Pacific Biosciences of California, Inc. (PACB)

2.21 -0.14 (-5.96%) USD  |  NASDAQ  |  Jan 16, 16:00
2.22 +0.01 (+0.45%) After-Hours: 20:00
More

Pacific Biosciences of California Current Deferred Revenue (Per Share)

Current Deferred Revenue (Per Share) Chart

View Current Deferred Revenue (Per Share) for PACB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Current Deferred Revenue (Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Current Deferred Revenue (Per Share) Range, Past 5 Years

View Current Deferred Revenue (Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Current Deferred Revenue (Per Share) Benchmarks

View Current Deferred Revenue (Per Share) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Intellia Therapeutics, Inc. Upgrade
Twist Bioscience Corp. Upgrade
Beam Therapeutics, Inc. Upgrade
Bruker Corp. Upgrade